These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Treatment
80 results:

  • 1. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Inhibition of CSF1R and KIT With Pexidartinib Reduces Inflammatory Signaling and Cell Viability in Endometriosis.
    Dunn TN; Cope DI; Tang S; Sirupangi T; Parks SE; Liao Z; Yuan F; Creighton CJ; Masand RP; Alpuing Radilla L; Guan X; Detti L; Monsivais D; Matzuk MM
    Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38227801
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Overexpressing lipid raft protein STOML2 modulates the tumor microenvironment via NF-κB signaling in colorectal cancer.
    Gong H; Chen S; Liu S; Hu Q; Li Y; Li Y; Li G; Huang K; Li R; Fang L
    Cell Mol Life Sci; 2024 Jan; 81(1):39. PubMed ID: 38214751
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network.
    Xu L; Zhang H; Shao Y; Fu Z
    PLoS One; 2023; 18(12):e0295126. PubMed ID: 38064496
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
    Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
    Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
    BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Yiqi Huayu Jiedu Decoction inhibits liver metastasis of colorectal cancer via enhancing natural killer cells function.
    Zhou JY; Wu C; Shen Z; Liu S; Zou X; Qian J; Wu Z; Huan X; Mu BX; Ye N; Ning Y; Wang Y; Chen M; Zhuang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116915. PubMed ID: 37451487
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors.
    Kim JY; Jung J; Kim KM; Lee J; Im YH
    Cancer Med; 2023 Jun; 12(11):12438-12451. PubMed ID: 37081749
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metformin and thymoquinone co-treatment enhance 5-fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon cancer cells.
    Farrash WF; Aslam A; Almaimani R; Minshawi F; Almasmoum H; Alsaegh A; Iqbal MS; Tabassum A; Elzubier ME; El-Readi MZ; Mahbub AA; Idris S; Refaat B
    Biofactors; 2023; 49(4):831-848. PubMed ID: 36929658
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
    Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
    Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in colorectal cancer.
    Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intra- and interobserver agreement of rectal cancer staging with MRI.
    Kilickap G; Dolek BA; Ercan K
    Acta Radiol; 2023 May; 64(5):1747-1754. PubMed ID: 36476121
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Studies on Chemical Composition of
    Fang X; Zhang Y; Cao Y; Shan M; Song D; Ye C; Zhu D
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364084
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
    Hassabo AA; Abdelraof M; Allam RM
    Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With colorectal cancer.
    Moretz C; Byfield SD; Hatchell KE; Dalton J; Onglao PN; Hang L; Hansen P; Radford C; Nielsen SM; Heald B; Munro SB; Nussbaum RL; Esplin ED
    JAMA Netw Open; 2022 Oct; 5(10):e2238167. PubMed ID: 36279135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
    Yadav P; Sharma P; Chetlangia N; Mayalagu P; Karunagaran D
    Chem Biol Interact; 2022 Dec; 368():110224. PubMed ID: 36272469
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Enhanced anti-cancer effects of oestrogen and progesterone co-therapy against colorectal cancer in males.
    Mahbub AA; Aslam A; Elzubier ME; El-Boshy M; Abdelghany AH; Ahmad J; Idris S; Almaimani R; Alsaegh A; El-Readi MZ; Baghdadi MA; Refaat B
    Front Endocrinol (Lausanne); 2022; 13():941834. PubMed ID: 36263327
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Additive Effect of CD73 Inhibitor in colorectal cancer treatment With CDK4/6 Inhibitor Through Regulation of PD-L1.
    Noh JY; Lee IP; Han NR; Kim M; Min YK; Lee SY; Yun SH; Kim SI; Park T; Chung H; Park D; Lee CH
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):769-788. PubMed ID: 35843546
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study.
    Qi LN; Ma L; Wu FX; Chen YY; Xu JX; Peng YC; Chen ZS; Gong WF; Yang CL; Wei HW; Qin SL; Shang JJ; Wang QY; Yu HP; Peng T; Huang YW; Ling YC; Tang WZ; Xiang BD; Li LQ
    Liver Int; 2022 Oct; 42(10):2283-2298. PubMed ID: 35810457
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.
    Huang Y; Zhang X; PengWang ; Li Y; Yao J
    BMC Genom Data; 2022 Jun; 23(1):48. PubMed ID: 35733095
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.